Personalis at Biomarkers EU Congress – 2020: February 19-20


Erin Newburn, MS, PhD
Associate Director, Field Application Scientist

Wednesday, February 19 | 9:00 AM

Maximizing Immunotherapy Biomarker Discovery with an Advanced Tumor Immunogenomics Platform

  • The complexity of the tumor and tumor microenvironment suggests a comprehensive approach is required for accurate characterization of the broader cancer ecosystem
  • The ImmunoID NeXT platform consolidates multiple biomarker assays into one with the ability to detect neoantigens, characterize the immune repertoire and identify novel biomarker signatures from a single sample
  • Featuring a case study demonstrating the ability of this immunogenomics profiling platform to uncover tumor escape mechanisms

Visit our exhibit at Biomarkers EU Congress 2020